Company / Inventory
RIGEL PHARMACEUTICALS INC Inventory History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$11.5M
FY2025
5-year range
$5.5M / $11.5M
FY2021-FY2025
Trend
+91.7%
vs FY2024
Sector context
#86 of 105
Health Care
What the data says
RIGEL PHARMACEUTICALS INC's inventory of $12M is lower than 82% of companies in the Health Care sector (FY2025). Improved from $6M to $12M over the past 2 years.
Based on SEC 10-K filings.
$12M in FY2025 with a 5-year CAGR of +47.7%.
Improved from $6M to $12M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +8.1%
- 5-Year CAGR
- +47.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 105This company $11.5M Sector average $885.3M
▼
-98.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +47.7%, indicating consistent growth.
- In FY2025, inventory increased 91.7% year-over-year.
- Ranks #86 out of 105 companies in the Health Care sector.
- Lowest inventory in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.5M | +91.7% |
| FY2024 | $6.0M | +8.7% |
| FY2023 | $5.5M | -39.4% |
| FY2022 | $9.1M | +37.8% |
| FY2021 | $6.6M | +303.9% |
| FY2020 | $1.6M | +21.0% |
| FY2019 | $1.4M | +51.5% |
| FY2018 | $894.0K | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026